MMAE-SMCC

• Target:

  Drug-Linker Conjugates for ADC|||Microtubule Associated

• Related Pathways:

  Cytoskeletal Signaling|||Antibody-drug Conjugate/ADC Related

• Purity:

  0.9704

• Bioactivity:

  MMAE-SMCC comprises the antitumour microtubule inhibitor MMAE and the non-cleavable ADC linker SMCC, enabling the preparation of antibody-drug conjugates (ADCs) .

• Smiles:

  [C@H]([C@H](C(N[C@@H]([C@@H](O)C1=CC=CC=C1)C)=O)C)(OC)[C@]2(N(C(C[C@H]([C@@H](N(C([C@@H](NC([C@@H](N(C(CCSC3C(=O)N(CC4CCC(C(ON5C(=O)CCC5=O)=O)CC4)C(=O)C3)=O)C)[C@@H](C)C)=O)C(C)C)=O)C)[C@H](CC)C)OC)=O)CCC2)[H]

• Molecular Formula:

  C58H89N7O14S

• Molecular Weight:

  1140.43

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2021179-11-1